文献速递消化与肝胆胰病理细胞病理与分子病理

胰腺病变残留细胞学固定液DNA二代测序初探

Next-generation sequencing of residual cytologic fixative preserved DNA from pancreatic lesions: A pilot study.
PubMed 文献 · Cancer Cytopathol · 2020-06-29

本研究探索利用胰腺EUS-FNA残留酒精固定液提取DNA进行二代测序的可行性,对39例患者的42份残留固定液样本测序。黏液性囊肿中71.4%检出临床显著变异,PDAC中66.7%有KRAS改变,NET均未检出变异,提示残留固定液DNA可作为NGS的潜在来源。

要点

  • 残留酒精固定液DNA可成功用于胰腺病变NGS检测。
  • 黏液性囊肿和PDAC中KRAS、GNAS、TP53变异检出率较高。
  • NET样本未检出变异,NB样本仅11.1%检出变异。

核心结论

  • 残留酒精固定液来源DNA是尚未充分利用的NGS样本来源。
  • 对残留固定液DNA测序有潜力整合进胰腺穿刺样本的诊疗流程并可能影响管理。

研究设计与样本

  • pilot研究,收集39例因胰腺病变行EUS-FNA患者的42份残留细胞学固定液样本。
  • 结合人口学、影像学和实验室检查,按细胞病理评估分为NB、MC、PDAC或NET。
  • 样本在Oncomine平台(ThermoFisher Scientific)进行测序。

主要发现

  • 所有NET均未检出变异。
  • 9例NB穿刺样本中仅1例(11.1%)检出KRAS和MAP2K变异。
  • 5例配对FFPE组织中4例(80%)检出与固定液DNA一致的变异。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) is a sensitive and specific tool in the risk stratification of pancreatic lesions, including cysts. The sensitivity and specificity of EUS-FNA has been shown to improve when cytology is combined with next-generation sequencing (NGS). Ideally, fresh cyst fluid is used for NGS. In this pilot study, we explore the possibility of sequencing DNA derived from residual alcohol-fixed pancreatic aspirates. METHODS: Residual cytologic fixatives (n = 42) from 39 patients who underwent EUS-FNA for pancreatic lesions were collected along with demographics, imaging, and laboratory studies. Samples were designated as nonneoplastic/nonmucinous benign (NB), mucinous cyst (MC), pancreatic ductal adenocarcinoma (PDAC), or well-differentiated neuroendocrine tumor (NET) on the basis of cytopathologic evaluation and sequenced on the Oncomine platform (ThermoFisher Scientific, Waltham, Massachusetts). RESULTS: Ten of 14 (71.4%) MCs exhibited clinically significant variants, including KRAS, GNAS, and TP53. Ten of 15 (66.7%) PDACs had KRAS alterations, and 9 of 15 (60%) showed variants in TP53. No variants were detected in any NETs. Only 1 of 9 (11.1%) NB aspirates showed variants in KRAS and MAP2K. Sequencing of formalin-fixed, paraffin-embedded tissue revealed variants identical to those detected in fixative-derived DNA in 4 of 5 cases (80%). CONCLUSION: Residual DNA from alcohol-fixed aspirates are an underutilized source for NGS. Sequencing residual fixative-derived DNA has the potential to be integrated into the workup of pancreatic aspirates, possibly impacting management.

来源:Cancer Cytopathol,查看原文。版权归原作者所有。

引用

  1. Fulmer CG, Park K, Dilcher T, et al. Next-generation sequencing of residual cytologic fixative preserved DNA from pancreatic lesions: A pilot study. Cancer Cytopathol. 2020. PMID: 32598087. doi:10.1002/cncy.22315

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。